News | April 08, 2023
Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
The summit encompasses multiple verticals, spanning from pharmaceuticals, biotech, life sciences, and the Healthcare sector to ensure an unbiased and comprehensive view on the future of the function.
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Subscribe To Our Newsletter & Stay Updated
